TechInAfrica – According to President Cyril Ramaphosa, South Africa is prepared to construct a new center to produce COVID-19 vaccines.
Along with French President Emmanuel Macron, Ramaphosa delivered a speech at a joint conference on Monday. The conference was made by the World Health Organisation (WHO).
The partnership between South Africa and the French was the result of the French President’s visit to South Africa at the end of last month.
According to WHO Director-General Tedros Adhanom Ghebreyesus, the organization presented a call for Expression of Interest on 16 April to set up a vaccine-producing center in South Africa. It is expected that the hubs can increase the manufacturing and access to the jab in South Africa.
The first company who answered the call from WHO was South Africa’s Biovac Institute. Previously collaborating with France, Biovac Institute worked on a more advanced partnership with Afrigen Biologics and Vaccines, the Africa Centres for Disease Control and Prevention (ACDCP. The institute also partners with a network of universities to initiate the continent’s first COVID messenger RNA vaccine technology transfer hub.
Vaccines for all of Africa
Ramaphosa mentioned that the commencement should carry advantages not only for South Africa but also for the continent. Ramaphosa continued that the milestone initiative is a crucial advance in the global attempt to construct vaccine development and produce a volume that will settle Africa on a path to self-determination.
South Africa accepts the chance to create a vaccine technology transport hub and to set up on the scope and competence that has existed on the continent to contribute to this endeavor. French President Emmanuel Macron stated that he was proud of Biovac and his South African partners to have been chosen by WHO, as France has been supporting Africa for years.
In the future, France will continue supporting initiatives with balanced access to vaccines, promised Emmanuel Macron.